The impact of the SARS-CoV-2 pandemic on the prevalence of respiratory tract pathogens in patients with community-acquired pneumonia in Germany
Theo Dähne, Wolfgang Bauer, Andreas Essig, Bernhard Schaaf, Christoph D. Spinner, Mathias W. Pletz, Gernot Rohde, Jan Rupp, Martin Witzenrath, Marcus Panning, Members of the CAPNETZ study group
Abstract
We show a shift in the prevalence of respiratory viral pathogens in community-acquired pneumonia patients during the COVID-19 pandemic. Our data support the efficiency of non-pharmaceutical interventions on virus circulation except for rhinoviruses. The consequences of an altered circulation on subsequent winter seasons remain unclear and support the importance of systematic virological surveillance.
Topics & Concepts
PandemicPneumoniaMedicineRespiratory systemViral pneumoniaCoronavirus disease 2019 (COVID-19)Respiratory tract infectionsRespiratory tractVirologyRhinovirusPsychological interventionSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirusIntensive care medicineImmunologyInternal medicineDiseaseInfectious disease (medical specialty)PsychiatryCOVID-19 epidemiological studiesRespiratory viral infections researchInfluenza Virus Research Studies